Nimodipine Reappraised: An Old Drug with a Future

Nimodipine is a dihydropyridine calcium channel antagonist that blocks the flux of extracellular calcium through L-type, voltage-gated calcium channels. While nimodipine is FDA-approved for the prevention and treatment of neurological deficits in patients with aneurysmal subarachnoid hemorrhage (aSA...

Descripción completa

Detalles Bibliográficos
Autores principales: Carlson, Andrew P., Hänggi, Daniel, Macdonald, Robert L., Shuttleworth, Claude W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2020
Materias:
Neuropharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327937/
https://www.ncbi.nlm.nih.gov/pubmed/31560289
http://dx.doi.org/10.2174/1570159X17666190927113021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327937/
https://www.ncbi.nlm.nih.gov/pubmed/31560289
http://dx.doi.org/10.2174/1570159X17666190927113021

Ejemplares similares